Related references
Note: Only part of the references are listed.Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
Toni K. Choueiri et al.
CANCER (2007)
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T. K. Choueiri et al.
ANNALS OF ONCOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment outcome for metastatic papillary renal cell carcinoma patients
Ellen A. Rormen et al.
CANCER (2006)
The pathology of renal epithelial neoplasms
Victor E. Reuter
SEMINARS IN ONCOLOGY (2006)
The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma
Toni K. Choueiri et al.
SEMINARS IN ONCOLOGY (2006)
2004 WHO classification of the renal tumors of the adults
A Lopez-Beltran et al.
EUROPEAN UROLOGY (2006)
Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy
MP Upton et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Molecular classification of papillary renal cell carcinoma
XMJ Yang et al.
CANCER RESEARCH (2005)
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma
TM Mekhail et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Expression of vascular endothelial growth factor protein in human renal cell carcinoma
J Jacobsen et al.
BJU INTERNATIONAL (2004)
Overexpression of KIT in chromophobe renal cell carcinoma
K Yamazaki et al.
ONCOGENE (2003)
Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases
B Delahunt et al.
HUMAN PATHOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
